CS18991A2 - Recombinant plasmid - Google Patents

Recombinant plasmid Download PDF

Info

Publication number
CS18991A2
CS18991A2 CS91189A CS18991A CS18991A2 CS 18991 A2 CS18991 A2 CS 18991A2 CS 91189 A CS91189 A CS 91189A CS 18991 A CS18991 A CS 18991A CS 18991 A2 CS18991 A2 CS 18991A2
Authority
CS
Czechoslovakia
Prior art keywords
plasmid
items
promoter
plasmid according
virus
Prior art date
Application number
CS91189A
Other languages
Czech (cs)
English (en)
Inventor
Walter Dr Bodemer
Friedrich Ing Scheiflinger
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of CS18991A2 publication Critical patent/CS18991A2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS91189A 1990-01-29 1991-01-28 Recombinant plasmid CS18991A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4002521A DE4002521A1 (de) 1990-01-29 1990-01-29 Rekombinantes plasmid

Publications (1)

Publication Number Publication Date
CS18991A2 true CS18991A2 (en) 1991-09-15

Family

ID=6398977

Family Applications (1)

Application Number Title Priority Date Filing Date
CS91189A CS18991A2 (en) 1990-01-29 1991-01-28 Recombinant plasmid

Country Status (8)

Country Link
EP (1) EP0443335A1 (de)
JP (1) JPH0515374A (de)
CA (1) CA2034564A1 (de)
CS (1) CS18991A2 (de)
DE (1) DE4002521A1 (de)
FI (1) FI910426A (de)
HU (1) HUT61331A (de)
NO (1) NO910331L (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180157B1 (de) * 1999-05-28 2012-11-28 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Vacciniavirus-vektor, dem gleichzeitig ein wachstumsfaktor und die thymidinkinase fehlen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2583429B1 (fr) * 1985-06-18 1989-11-03 Transgene Sa Vecteur d'expression de l'interferon u dans les cellules de mammifere, procede pour sa mise en oeuvre et produit obtenu et composition pharmaceutique contenant l'interferon u
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
DE3853693D1 (de) * 1987-03-20 1995-06-08 Immuno Ag DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
GB8724885D0 (en) * 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
WO1989008716A1 (en) * 1988-03-18 1989-09-21 The United States Of America, As Represented By Th Novel recombinant vaccinia virus expression vectors and method of selecting same

Also Published As

Publication number Publication date
DE4002521A1 (de) 1991-08-01
NO910331D0 (no) 1991-01-29
CA2034564A1 (en) 1991-07-30
JPH0515374A (ja) 1993-01-26
HUT61331A (en) 1992-12-28
FI910426A0 (fi) 1991-01-29
FI910426A (fi) 1991-07-30
HU910289D0 (en) 1991-08-28
NO910331L (no) 1991-07-30
EP0443335A1 (de) 1991-08-28

Similar Documents

Publication Publication Date Title
Davis et al. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles
KR101454842B1 (ko) 개선된 알파바이러스 레플리콘 및 헬퍼 구축물
Earl et al. Comparison of vaccine strategies using recombinant env–gag–pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model
EP1240186B1 (de) Verbesserungen in oder in bezug auf immunantworten gegen hiv
US11571471B2 (en) Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccine
KR20230134155A (ko) 재조합 변형된 백시니아 바이러스 앙카라 (mva) 필로바이러스 백신
US6653125B2 (en) Synthetic hepatitis C genes
US20030013076A1 (en) Parapoxvirus vectors
JP2001514518A (ja) 発現の向上したベクター並びにその製造および使用方法
CN107574156A (zh) 类病毒组合物颗粒及其使用方法
JP2002186494A (ja) 組換えワクシニアウイルス
CN113845576B (zh) 重组猫疱疹病毒1型gB-gD蛋白及其应用
EP0753581A1 (de) Verbesserte rekombinante eukaryotische zytoplasmatische Viren, Methode ihrer Herstellung und ihrer Verwendung als Impfstoffe
CA2086740A1 (en) Equine herpesvirus-4 tk-vaccine
CN113073106B (zh) 新型冠状病毒b.1.525尼日利亚突变株rbd的基因及其应用
CN104428417B (zh) 利用针对确定抗原产生保护性体液免疫应答的重组酵母进行的接种
JP2005525119A (ja) 組換え鶏痘ウイルス
KR20140039972A (ko) 재조합 백신 개발을 위한 효모 야로위아 리폴리티카에서 코돈 최적화된 원형 및 n 단편-절단 형태의 노다 캡시드 단백질 생산 방법
CS18991A2 (en) Recombinant plasmid
AU622129B2 (en) Vector for the expression of proteins of the hiv-2 virus, one of the casual agents of aids, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
Van der Ryst et al. Study of the immunogenicity of different recombinant Mengo viruses expressing HIV1 and SIV epitopes
KR20230008707A (ko) 코로나바이러스 치료용 백신 조성물
CA3202140A1 (en) Genomic deletion in african swine fever vaccine allowing efficient growth in stable cell lines
US5426051A (en) Gene for A-type inclusion body of poxvirus
EP0261925B1 (de) Gen für A-Typ-Einschliesskörper des Poxvirus, seine Herstellung und Verwendung